Skip to main content
. 2021 Jun;42(6):620–628. doi: 10.15537/smj.2021.42.6.20200753

Table 2.

- Laboratory data of the studied groups (N=150).

Variables Rheumatoid arthritis patients Group III (control) (n=50) Test of significance P-value
Group I (n=50) Group II (n=50)
Hb (gm/dl) 10.6 ± 1.0 10.3 ± 1.1 13.1 ± 0.4 14.5 <0.001
Post Hoc     P1=0.247, P2<0.001, P3<0.001    
WBCs (cells/μL) 5.4 ± 1.7 5.9 ± 1.5 5.5 ± 1.1 1.6 0.199
Post Hoc     P1=0.186, P2=0.852, P3=0.441    
PLT (103/μL) 259.4 ± 100.6 265.5 ± 82.2 282.3 ± 48.2 0.9 0.408
Post Hoc     P1=0.922, P2=0.394, P3=0.627    
ESR (mm/hr) 24.3 ± 13.2 84.4 ± 32.5 6.3 ± 1.5 20.2 <0.001
Post hoc     P1<0.001, P2 <0.001, P3 <0.001    
CRP (mg/dL) 12.9 ± 9.7 42.2 ± 11.1 5.02 ± 1.1 26.2 <0.001
Post Hoc     P1<0.001, P2<0.001, P3<0.001    
RBG (mg/dl) 100.4 ± 14.1 100.0 ± 12.9 100.1 ± 12.7 0.14 0.986
Post hoc     P1=0.988, P2=0.988, P3=1.00    
Total cholesterol (mg/dl) 178.4 ± 21.0 177.1 ± 21.1 165.6 ± 20.7 5.6 0.004
Post hoc     P1=0.948, P2=0.008, P3=0.019    
TG (mg/dl) 136.6 ± 21.8 141.3 ± 21.3 120.1 ± 19.2 13.8 <0.001
Post hoc     P1=0.493, P2<0.001, P3<0.001    
LDL (mg/dl) 87.06 ± 7.0 88.5 ± 7.3 84.6 ± 6.3 4.0 0.020
Post hoc     P1=0.518, P2=0.202, P3=0.015    
HDL (mg/dl) 49.1 ± 6.2 48.2 ± 5.7 55.1 ± 4.6 22.7 <0.001
Post hoc     P1=0.657, P2<0.001, P3<0.001    
Atherogenic index 0.08 ± 0.1 0.1 ± 0.1 0.01 ± 0.1 7.6 0.001
Post hoc     P1=0.717, P2=0.011, P3=0.001    
Data are expressed as mean ± SD. Hb: Hemoglobin, WBCS: white blood cells, PLT: platelets, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, RBG: random blood glucose. TG: triglycerides, LDL: low density lipoprotein, HDL: high density lipoprotein. P1: Group I vs II, P2: Group I vs III, P3: Group II vs III. P<0.05 is significant. P≤0.001 is highly significant.